15-PGDH inhibitor
US-12577217-B2 · Mar 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Eight-membered rings
Eight-membered rings · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D267/22 |
| Official title | Eight-membered rings |
| Display label | Eight-membered rings |
| Total patents | 18 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Novel, reversible dpp1 inhibitors and uses thereof
US-2026055093-A1 · Feb 26, 2026 · US
Dipeptidyl peptidase 1 inhibitors and uses thereof
US-2026008760-A1 · Jan 8, 2026 · US
Reversible DPP1 inhibitors and uses thereof
US-12479837-B2 · Nov 25, 2025 · US
Reversible dpp1 inhibitors and uses thereof
US-2025223284-A1 · Jul 10, 2025 · US
Four-membered fused ring compound and preparation method and use thereof
US-2024400582-A1 · Dec 5, 2024 · US
Small molecule inhibitors of kras g12c mutant
US-2024262842-A1 · Aug 8, 2024 · US
15-pgdh inhibitor
US-2023082516-A1 · Mar 16, 2023 · US
Azocane and azonane derivatives and methods of treating hepatitis B infections
US-10537580-B2 · Jan 21, 2020 · US
Bicyclic [4,6,0] hydroxamic acids as hdac inhibitors
US-2019345149-A1 · Nov 14, 2019 · US
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
US-10407418-B2 · Sep 10, 2019 · US
Bicyclic [4,6,0] hydroxamic acids as hdac inhibitors
US-2019092762-A1 · Mar 28, 2019 · US
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
US-10183934-B2 · Jan 22, 2019 · US
Azocane and azonane derivatives and methods of treating hepatitis b infections
US-2018201590-A1 · Jul 19, 2018 · US
Azocane and azonane derivatives and methods of treating hepatitis B infections
US-9884831-B2 · Feb 6, 2018 · US
Azocane and azonane derivatives and methods of treating hepatitis b infections
US-2016272599-A1 · Sep 22, 2016 · US
Bicyclic [4,6,0] hydroxamic acids as hdac inhibitors
US-2016221997-A1 · Aug 4, 2016 · US
4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases
US-9266848-B2 · Feb 23, 2016 · US